Top Purchase Related
Home
>
Node
>
Subnode

Drug therapy for breast cancer

Daly, P.A.

Irish Medical Journal 87(5): 128; 130

1994

ISSN/ISBN: 0332-3102
PMID: 7960646
Document Number: 430720

Document emailed within 1 workday
Secure & encrypted payments

Castiglione, M.; Schnürch, H.G.; Bender, H.G.; Goldhirsch, A. 1994: Principles of adjuvant drug therapy in breast cancer Der Gynakologe 27(2): 49-63
Hudis, C.A.; Norton, L. 1996: Adjuvant drug therapy for operable breast cancer Seminars in Oncology 23(4): 475-493
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712
Chekhun, V.F.; Zhylchuk, V.E.; Lukyanova, N.Y.; Vorontsova, A.L.; Kudryavets, Y.I. 2009: Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients Experimental Oncology 31(2): 123-124
Rosenberg, L.; Palmer, J.R.; Shapiro, S. 1992: Oestrogen replacement therapy and breast cancer Results from the Slone Epidemiology Units Toronto Breast Cancer Study Mann, R D Hormone replacement therapy and breast cancer risk : 253-264
Castiglione-Gertsch, M.; Tattersall, M.; Hacking, A.; Goldhirsch, A.; Gudgeon, A.; Gelber, R.D.; Lindtner, J.; Coates, A.; Collins, J.; Isley, M.; Senn, H.J.; Rudenstam, C.M. 1997: Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group European Journal of Cancer 33(14): 2321-2325
Hooning, M.J.; van Dongen, J.A.; Went, G. 1991: Changing indications for breast conserving therapy: proportion of patients with operable breast cancer suitable for breast conservation Netherlands Journal of Surgery 43(4): 102-104
Thomsen, K. 1987: Changes in the therapy of operable breast cancer. Treatment of small breast cancer and preinvasive stages Fortschritte der Medizin 105(22): 425-428
Ohsumi, S.; Takashima, S.; Saeki, T.; Aogi, K. 2002: Breast-conserving therapy consisting of wide excision, axillary dissection, and radiotherapy for early-stage breast cancer: the experience of the National Shikoku Cancer Center Biomedicine and PharmacoTherapy 56(Suppl): 196s-200s
Tominaga, T.; Abe, O.; Izuo, M.; Isono, K.; Enomoto, K.; Nishi, M.; Fukami, A.; Muto, T.; Morioka, Y.; Watanabe, H. 1993: Correlations between estrogen receptor and prognostic factors of patients with breast cancer. the Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2171-2176
Mitsuyama, S.; Kuroda, Y.; Ohsato, K.; Nakamura, Y.; Murakami, F.; Nishikata, F.; Ikeda, S.; Egami, T.; Mori, A.; Ohe, H. 1996: Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(9): 1153-1160
Friedrich, M. 2000: Vitamin D and breast cancer: new approaches for hormonal therapy of breast cancer Clinical and Experimental Obstetrics and Gynecology 27(2): 77-82
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
de la Torre, M.; Hao, X.Y.; Larsson, R.; Nygren, P.; Tsuruo, T.; Mannervik, B.; Bergh, J. 1993: Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases Anticancer Research 13(5a): 1425-1430
Tangkaratt, S. 2004: Mammographic findings in breast cancer patients, who were treated with breast conserving therapy Journal of the Medical Association of Thailand 87(12): 1439-1443
Lüscher, N.J. 1992: Reconstructive measures in local recurrence after breast saving therapy of breast cancer Helvetica Chirurgica Acta 59(1): 181-187
Seewald, D.H.; Zoidl, J.P.; Track, C.; Putz, E.; Hammer, J. 1994: Quality assurance of interstitial irradiation in the breast-conserving therapy of breast cancer Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 170(3): 147-150
Yoshida, M.; Saji, S.; Takagi, H.; Takeuchi, S.; Tsuda, H.; Nimura, Y.; Mizumoto, R.; Miyazaki, I.; Kobayashi, S.; Noguchi, M. 1993: A comparative study among ftorafur, ftorafur plus tamoxifen, and tamoxifen in adjuvant therapy for breast cancer. the Chubu Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(15): 2325-2333
Mannell, A. 2005: Breast-conserving therapy in breast cancer patients--a 12-year experience South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie 43(2): 28-30; Discussion 30, 32
Von Fournier, D.; Wannenmacher, M.; Hirsch, J. 1992: Josef Hirsch--pioneer of breast saving therapy of breast cancer Zentralblatt für Gynakologie 114(4): 201-203